Verified Document

Merck's Medco The Acquisition Of Medco by Essay

Merck's Medco The acquisition of Medco (by Merck) is a sign of shifts that are taking place in the health care industry. What is happening is there has been an emphasis on providing total health care solutions to consumers. As they are demanding that they have access to: the best services and want to have their different needs combined into one plan. This has lead to changes in the way health care services are delivered. As a variety of managed care plans have emerged to address these issues. Simply put, this is a health organization that will have their members pay them fees for the various services they require. As, this organization will negotiate with health care providers and drug manufactures; to offer their members the most cost effective solutions for addressing these different issues. Part of the reason for this, is because health care costs have been increasing dramatically and employers / individuals have been seeking out other solutions for addressing the problem.

In the case of Merck, they realized that they are facing tremendous challenges, by only being focused exclusively on the pharmaceutical industry. This pushed the company to purchase Medco, as a way to diversify their business model and respond to the changes that are taking place inside the sector. However, there have been differing opinions on the merger, with some executives believing that this will increase the overall bottom line. While there are other executives, who feel that the profit margins are so small that this is not a financially prudent decision moving forward. To see the true impact that this acquisition is having on Merck requires: examining these different views and determining the effect that it will have on the bottom line. Together, these different elements will provide the greatest insights, as to if the purchase of Medco is considered to be a wise decision for the organization. ("Merck and Company") ("Merck Medco Managed Care")

The different Views of Executives

Executives are divided on if: the acquisition of the Medco will increase the overall bottom line. As many of the Wall Street analysts believe that this action will help to increase the underlying amounts of long-term profitability. A good example of this...

Part of the reason for this, is because Medco is considered to: have a large customer base and the ability to cross market different services to them. As a result, a number of different drug manufacturers were talking with the Medco about: conducting some kind of strategic partnership or acquisition. According to proponents, the purchase of the company will have a number of different benefits. As, this will help Merck to become a major player inside: the pharmaceutical and managed care industries. A good example of this can be seen by looking at the size of the combined entity after the merger was complete. In this case, the acquisition would help to Merck to become one of the largest health care providers. The below charts illustrate the dominance that the new company inside the sector. ("Merck and Company") ("Merck Medco Managed Care")
("Merck Medco Managed Care")

("Merck Medco Managed Care")

The two charts are showing how without the acquisition, Merck was just another drug company. However, once it was complete, is when they would become a major player in: managed care services and pharmaceuticals. Evidence of this can be seen by comparing the revenues of the company between 1997 and 2001. As, this would increase from: $9 billion in 1997 to $26 billion in 2001. The below table illustrates the overall amounts of earnings growth that took place during this time. (Herper) ("Merck Medco Managed Care")

Revenues for the Combined Company between 1997 and 2001

Year

Revenues

1997

$9 billion

1999

$15 billion

2001

$26 billion

(Herper) ("Merck Medco Managed Care")

This is significant, because it shows how the merger between the two different companies caused the overall amount of revenues to increase dramatically. As Merck Medco, quickly became one of the most dominate players inside the industry by: offering a host of different services and products to consumers. In this aspect, various executives argued that…

Sources used in this document:
Bibliography

Merck and Company. The Pharma Letter, 1993. Web. 18 Mar. 2011

<http://www.thepharmaletter.com/file/58287/-merck-co-purchase-of-medco-revolutionary.html>

Merck Medco Managed Care. The Pharma Letter, n.d. Web. 18 Mar. 2011

<http://www.marketresearch.com/Vendors/SampleViewer/unlock.ncp?vendorid=2339&g=1>
Herper, Matthew. "Merck Decides to at it Alone. Forbes, 2002. Web. 18 Mar. 2011 <http://www.forbes.com/2002/01/29/0129merck.html>
MLA Format. http://owl.english.purdue.edu/owl/resource/747/01/
Cite this Document:
Copy Bibliography Citation

Related Documents

Mergers and Acquisitions
Words: 2337 Length: 9 Document Type: Business Proposal

Merger & Acquisitions MERGER AND ACQUISTION Merger and Acquisition Merck & Company Inc. is an American pharmaceutical company operating in different countries globally. The company is one of the world largest manufacturers of drugs by revenue and market capitalization, and the company offers different products such as vaccines, prescription products, consumer products and animal products. Its operative business is being operated by MerckKGaA where 30% of the shares are publicly traded and the

Leveraged Buyout Refers to the Acquisition Strategy
Words: 1503 Length: 5 Document Type: Term Paper

Leveraged buyout refers to the acquisition strategy whereby the target companies is acquired with the help of borrowed money usually bonds or loans. The acquiring company usually borrows money to buy another company and thus minimum equity is involved. Usually LBOs work on the principle of 90/10 debt-equity ratios where 10% money comes from the acquiring company while ninety percent is borrowed funds. Li JIN and Fiona WANG (2001) write:

Direct to Consumer Advertising History of Drug
Words: 16271 Length: 59 Document Type: Term Paper

Direct to Consumer Advertising HISTORY OF DRUG ADVERTISING THE DTC ADVERTISING PHENOMENON CREATING DEMAND DECEPTIVE ADVERTISING - A WOLF IN SHEEP'S CLOTHING CAUSE OF DEATH PROFIT UTILIZATION, PRICING, AND DEMOGRAPHICS LEGISLATION, POLITICS AND PATENTS LEGISLATIVE INITIATIVES REGARDING DTC RECALLED and/or DEADLY DRUGS In order to provide the most efficient method of evaluation, the study will utilize existing stores of qualitative and quantitative data from reliable sources, such as U.S. Government statistical references, University studies, and the studies and publications of non-profit

Sign Up for Unlimited Study Help

Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.

Get Started Now